Literature DB >> 15289997

Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation.

Tai-Hing Lam1, Abu Saleh M Abdullah, Sophia S C Chan, Anthony J Hedley.   

Abstract

RATIONALE: There are over 300 million Chinese smokers, but use of nicotine replacement therapy (NRT) is rare. On the other hand, data on the factors associated with quitting and adherence to NRT use are scarce in the East.
OBJECTIVES: To describe adherence and other predictors of quitting smoking at the 12-month follow-up amongst Chinese smokers in Hong Kong.
METHODS: Chinese smokers (1186) who attended the Smoking Cessation Health Centre from August 2000 through January 2002 were studied. Trained counsellors provided individual counselling and carried out follow-up interviews. We used structured questionnaires at baseline and at 1, 3 and 12 months and an intention-to-treat approach for analysis.
RESULTS: Among those who received NRT (1051/1186), the prevalence of adherence (self-reported NRT use for at least 4 weeks) was 16% (95% confidence interval 14-18%). The 7-day point prevalence quit rate at 12 months (not smoking any cigarette during the past 7 days at the 12 month follow-up) was 27% (95% CI, CI 24-29%). Stepwise logistic regression model showed that adherence to NRT use, a higher income, good perceived health and having more confidence in quitting were significant predictors of quitting. The quit rate in the adherent group (40%) was greater than that of the non-adherent group (25%) (P<0.001). Older age, male, higher education, experience of NRT use, perceiving quitting as more difficult and willingness to pay were significant predictors of adherence.
CONCLUSIONS: Clinically significant smoking cessation rates can be achieved among Chinese smokers in a clinic-based smoking cessation service. The NRT adherence was low and low adherence was associated with a lower quit rate. Trials of interventions to improve adherence and increase quit rates are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289997     DOI: 10.1007/s00213-004-1971-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Do heavy smokers benefit from higher dose nicotine patch therapy?

Authors:  J D Killen; S P Fortmann; L Davis; L Strausberg; A Varady
Journal:  Exp Clin Psychopharmacol       Date:  1999-08       Impact factor: 3.157

2.  Predictors of quitting smoking: the NHANES I followup experience.

Authors:  W P McWhorter; G M Boyd; M E Mattson
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.

Authors:  R D Hurt; G A Croghan; T D Wolter; I T Croghan; K P Offord; G M Williams; M V Djordjevic; J P Richie; A M Jeffrey
Journal:  Nicotine Tob Res       Date:  2000-11       Impact factor: 4.244

4.  Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.

Authors:  R D Hurt; L C Dale; P A Fredrickson; C C Caldwell; G A Lee; K P Offord; G G Lauger; Z Marŭsić; L W Neese; T G Lundberg
Journal:  JAMA       Date:  1994-02-23       Impact factor: 56.272

5.  Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.

Authors: 
Journal:  JAMA       Date:  1991-12-11       Impact factor: 56.272

6.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

7.  Clinical application of two computerized diabetes management systems: comparison with the log-book method.

Authors:  A Ryff-de Lèche; H Engler; E Nützi; M Berger; W Berger
Journal:  Diabetes Res       Date:  1992-03

8.  Gender differences in the psychological determinants of cigarette smoking.

Authors:  Jean-François Etter; Alexander V Prokhorov; Thomas V Perneger
Journal:  Addiction       Date:  2002-06       Impact factor: 6.526

9.  Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.

Authors:  D P Sachs; U Säwe; S J Leischow
Journal:  Arch Intern Med       Date:  1993-08-23

10.  Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.

Authors: 
Journal:  BMJ       Date:  1993-05-15
View more
  55 in total

1.  Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse.

Authors:  Tanya R Schlam; Timothy B Baker; Stevens S Smith; Daniel M Bolt; Danielle E McCarthy; Jessica W Cook; Todd Hayes-Birchler; Michael C Fiore; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2020-10-29       Impact factor: 4.244

2.  Predictors of adherence to nicotine gum and counseling among African-American light smokers.

Authors:  Kolawole S Okuyemi; Hui Zheng; Hongfei Guo; Jasjit S Ahluwalia
Journal:  J Gen Intern Med       Date:  2010-05-21       Impact factor: 5.128

Review 3.  New methods for tobacco dependence treatment research.

Authors:  Timothy B Baker; Robin Mermelstein; Linda M Collins; Megan E Piper; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Michael C Fiore
Journal:  Ann Behav Med       Date:  2011-04

4.  Development of a Discrete Choice Experiment (DCE) Questionnaire to Understand Veterans' Preferences for Tobacco Treatment in Primary Care.

Authors:  David A Katz; Kenda R Stewart; Monica Paez; Mark W Vander Weg; Kathleen M Grant; Christine Hamlin; Gary Gaeth
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

5.  Early quit days among methadone-maintained smokers in a smoking cessation trial.

Authors:  Marcel A de Dios; Bradley J Anderson; Celeste M Caviness; Michael D Stein
Journal:  Nicotine Tob Res       Date:  2014-06-20       Impact factor: 4.244

6.  Nicotine gum or patch treatment for smoking cessation and smoking reduction: a multi-centre study in Chinese physicians.

Authors:  Dan Xiao; Nanshan Zhong; Chunxue Bai; Qingyu Xiu; Canmao Xie; Dayi Hu; Yun Mao; Roland Perfekt; Elisabeth Kruse; Qing Li; John Jiangnan Liu; Chen Wang
Journal:  Front Med       Date:  2014-01-23       Impact factor: 4.592

7.  Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.

Authors:  Gareth J Hollands; Stephen Sutton; Máirtín S McDermott; Theresa M Marteau; Paul Aveyard
Journal:  Nicotine Tob Res       Date:  2013-02-19       Impact factor: 4.244

Review 8.  Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence.

Authors:  Philip B Cawkwell; Caroline Blaum; Scott E Sherman
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

9.  Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.

Authors:  Robert C Culverhouse; Li-Shiun Chen; Nancy L Saccone; Yinjiao Ma; Megan E Piper; Timothy B Baker; Laura J Bierut
Journal:  Nicotine Tob Res       Date:  2020-02-06       Impact factor: 4.244

10.  Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.

Authors:  David Gonzales; Douglas E Jorenby; Thomas H Brandon; Carmen Arteaga; Theodore C Lee
Journal:  Addiction       Date:  2010-09-01       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.